ArticleVaccine2022

B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders.

Mégane Tanguay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.